# Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

> **NCT00136422** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 30 (—)

## Conditions studied

- Acute Myelogenous Leukemia
- Myelodysplasia

## Interventions

- **BIOLOGICAL:** autologous tumor cells

## Key facts

- **NCT ID:** NCT00136422
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 30 (—)
- **Last updated:** 2011-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136422, "Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00136422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*